Bio-Techne expands AI-engineered protein portfolio for cell therapy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
July 8, 2026 6:30 AM EDTAdvancing Scalable Reproducible Cell Therapy and Advanced Cell Culture Workflows
New heat-stable and hyperactive proteins across the fibroblast growth factor and interleukin cytokine families expand the R&D Systems AI-Engineered Designer Protein portfolioAI-guided protein design supports improved consistency, performance and scalability in complex cell culture workflows
Engineered signaling proteins help address key challenges in scaling cell therapy from discovery through manufacturing
MINNEAPOLIS, July 8, 2026 /PRNewswire/ --... More
